Status | Study |
Active, not recruiting |
Study Name: Symptom Inventory for Gastrointestinal Stromal Tumors Condition: Gastrointestinal Stromal Tumors Date: 2010-08-06 Interventions: Behavioral: Questionnaires 10 |
Completed |
Study Name: Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST) Condition: Gastrointestinal Stromal Tumor Date: 2010-04-22 Interventions: Drug: Nilotinib |
Completed |
Study Name: Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST) Condition: Gastrointestinal Stromal Tumors Date: 2009-09-11 Interventions: Drug: Nilotinib Nilotinib 400mg bid daily |
Terminated |
Study Name: Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate Condition: Gastrointestinal Stromal Tumor Date: 2009-08-08 Interventions: Drug: imatinib mesylate Patien |
Recruiting |
Study Name: Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001 Condition: Gastrointestinal Stromal Tumor Date: 2009-08-06 Interventions: Genetic: mutation analysis Genetic: polymo |
Completed |
Study Name: Treatment Patterns in Gastrointestinal Stromal Tumors in the Community Oncology Setting Condition: Gastrointestinal Stromal Tumors Date: 2009-04-03 |
Completed |
Study Name: A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment Condition: Gastrointestinal Stromal Tumors Date: 2008-12-19 Interventions: Drug: masitinib (AB1010) masit |
Terminated |
Study Name: Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor Condition: Gastrointestinal Stromal Tumor Date: 2008-05-22 Interventions: Drug: imatinib mesylate By mouth |
Terminated |
Study Name: Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors Condition: Gastrointestinal Stromal Tumor Date: 2007-12-13 Interventions: Drug: imatinib mesylate will s |
Active, not recruiting |
Study Name: Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors Condition: Gastrointestinal Stromal Tumor Date: 2007-12-05 Interventions: Drug: dasatinib Dasatinib is given orally 70 mg BID. Dasatinib will be continued until progression, unac |